Home > Legal Library > Abstract




Join Matindale-Hubbell Connected


The Use of Botulinum Toxin Products in Cosmetic Applications - What’s the Litigation Risk?



by Donna Marie Baloy
Wilson Elser Moskowitz Edelman & Dicker LLP - White Plains Office

July 17, 2014

Previously published on June 2014

Botulinum toxin products such as Botox® and Dysport® are used cosmetically for temporary improvement in the appearance of glabellar lines (“frown lines”) and lateral canthal lines (“crow’s feet”) in adults. Essentially, these products employ a neurotoxin, botulinum toxin type A, which works by weakening or paralyzing muscles and/or blocking nerves. In addition to its cosmetic uses, botulinum toxin is also approved by the FDA for use in a variety of therapeutic applications: overactive bladder, urinary incontinence, migraine headaches, upper limb spasticity, cervical dystonia (painful contraction of neck muscles), hyperhidrosis (severe underarm sweating), blepherospasm and strabisimus.


 

The views expressed in this document are solely the views of the author and not Martindale-Hubbell. This document is intended for informational purposes only and is not legal advice or a substitute for consultation with a licensed legal professional in a particular case or circumstance.
 

View More Library Documents By...

 
Author
 
Donna Marie Baloy
 
Wilson Elser Moskowitz Edelman & Dicker LLP Overview